Artificial intelligence (AI) is rapidly transforming the landscape of drug development, offering innovative solutions to complex challenges in the pharmaceutical industry. Recognizing the profound impact of AI, the U.S. Food and Drug Administration (FDA) has issued a draft guidance titled “Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological […]
